1



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13G


                    Under the Securities Exchange Act of 1934
                                (Amendment No.)*

                              HALSEY DRUG COMPANY INC
                            ____________________________
                                (Name of Issuer)


                                    COMMON                         
                           _________________________
                         (Title of Class of Securities)

                                   40636910
                          __________________________
                                (CUSIP Number)




*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).


 2




                                  SCHEDULE 13G

CUSIP No. 40636910

1.       NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

               CREDIT SUISSE ASSET MANAGEMENT
               13-3580284

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*    (a) [ ]
                                                              (b) [ ]

3.       SEC USE ONLY

4.       CITIZENSHIP OR PLACE OF ORGANIZATION

                  United States

                        5.     SOLE VOTING POWER      1,615,100     

NUMBER OF               6.     SHARED VOTING POWER    0   
SHARES
BENEFICIALLY 
OWNED BY
EACH                    7.     SOLE DISPOSITIVE POWER    1,615,100    
REPORTING
PERSON                  8.     SHARED DISPOSITIVE POWER  0       
WITH


9.       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
                         1,615,100

10.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES 
         CERTAIN SHARES*    

                   N/A

11.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9    
                   5.77%

12.      TYPE OF REPORTING PERSON*

                  Investment Advisor


                                *SEE INSTRUCTION

                                       

 3


                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549
                                  Schedule 13G
                    Under the Securities Exchange Act of 1934

Amendment No.:                                            

Item 1 (a)        Name of issuer:        

                       HALSEY DRUG COMPANY INC
 
Item 1 (b)        Address of issuer's principal executive offices:

                       1827 PACIFIC STREET
                       BROOKLYN, NY 11233

Item 2 (a)        Name of person filing:

                        CREDIT SUISSE ASSET MANAGEMENT

Item 2 (b)        Address of principal business office:

                        153 EAST 53RD STREET
                        NEW YORK, NEW YORK 10022

Item 2 (c)        Citizenship:      United States

Item 2 (d)        Title of class of securities:    COMMON 

Item 2 (e)        Cusip No.:   40636910     

Item 3            Type of Person: Investment Advisor

Item 4 (a)        Amount beneficially owned:  1,615,100                

Item 4 (b)        Percent of class:  5.77%

Item 4 (c)         (i)    sole power to vote:      1,615,100   
                   (ii)   shared power to vote:    0
                   (iii)  sole power to dispose:   1,615,100   
                   (iv)   shared power to dispose: 0     

Item 5   Ownership of 5 percent or less of a class:   Not Applicable

Item 6   Ownership of more than 5 percent on behalf of another
         person:    Not Applicable 





  4
 

Item 7   Identification and classification of subsidiary:    Not Applicable



Item 8   Identification and classification of members of 
         the group:  Not Applicable

Item 9   Notice of dissolution of the group:    Not Applicable

Item 10  Certification:

                  By signing below I certify that, to the best of my knowledge
                  and belief, the securities referred to above were acquired in
                  the ordinary course of business and were not acquired for the
                  purpose of and do not have the effect of changing or
                  influencing the control of the issuer of such securities and
                  were not acquired in connection with or as a participant in
                  any transaction having such purpose or effect.

                  After reasonable inquiry and to the best of my knowledge and
                  belief, I certify that the information set forth in this
                  statement is true, complete, and correct.

                                     FEBRUARY 16, 1999  
                                     --------------------------------
                                     Date

                                     /s/ HAL LIEBES
                                     --------------------------------
                                     HAL LIEBES         
                                     SVP/GENERAL COUNSEL